Chemical Compound Background 9 masthead

Director/PDMR Dealing

Posted date: March 27, 2024

Download Full Message Here

24 February 2021

Iofina plc
(“Iofina” or the “Company“)

Director/PDMR Dealing

Iofina plc (AIM: IOF) announces that it received notification on 23 February 2021 that Thomas M Becker, Chief Executive Officer and President of the Company, purchased a total of 30,680 ordinary shares in the capital of the Company at an aggregated price of 11.90 pence per share. Further details are set out in the Notification of Dealing Form below.

Following the purchase, Dr. Becker holds 124,430 shares, representing approximately 0.065 per cent. of the Company’s share capital. The shares purchased represent 0.016 per cent. of the Company’s issued share capital.

Director/PDMR Ordinary shares purchased Resultant interest in ordinary shares Resultant percentage of issued ordinary shares
Non-Executive Chairman 30,680 124,430 0.065%

 

This announcement contains inside information for the purposes of Article 7 of EU Regulation 596/2014.

Enquiries:
Dr. Tom Becker
CEO & President
Iofina plc
Tel: +1 859.354.3878

Christopher Raggett/Giles Rolls/Matthew Radley
Tim Redfern (ECM)
finnCap Ltd
Tel: +44 (0)20 7220 0500

Media Contact:
Charles Goodwin/Joe Burgess
Yellow Jersey PR Limited
Tel: +44 (0)7747 788 221

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

1

Details of the persons discharging managerial responsibilities / person closely associated

a)

Name

Thomas M Becker
2

Reason for the notification

a)

Position/Status

PDMR – Chief Executive Officer and President
b)

Initial notification/ Amendment

Initial notification
3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Iofina plc
b)

LEI

213800QDMFYVRJYYTQ84
4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

 

Identification code

 

Ordinary shares of £0.01 each

 

 

GB00B2QL5C79

b) Nature of the transaction

Purchase of ordinary shares

c)

Price(s) and volume(s)

Price(s) (p) Volume(s)
11.75p 100
11.75p 580
11.90p 30,000
d)

Aggregated information

 

– Aggregated volume

– Price

 

 

 

30,680

11.9p

e)

Date of transaction

22 February 2021 and 23 February 2021
f)

Place of transaction

London Stock Exchange, AIM Market (XLON)
Previous ArticleInterim Results Next ArticleUsing Iodine for Cow Health
Translate »